View Older Stories View More Recent Stories
-
One Stop Systems Announces Debt Financing
-
One Stop Systems Announces Debt Financing
-
Cyclacel Pharma (CYCC) Prices $20M Offering of Common Stock, Warrants
-
CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
-
Roth Capital Upgrades Landec (LNDC) to Buy
-
CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
-
Roth Capital Downgrades Goodrich Petroleum (GDP) to Neutral
-
Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Allied Motion Technologies (AMOT) PT Lowered to $44 at Roth Capital
-
Roth Capital Starts The Lovesac Co. (LOVE) at Buy
-
Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
MoSys (MOSY) Announces Pricing of $1.9 Million Registered Direct Offering of Common Stock
-
MoSys Announces Pricing of $1.9 Million Financing
-
Roth Capital Upgrades W&T Offshore (WTI) to Buy
-
Arcturus Therapeutics (ARCT) Prices 4.12M Share Common Stock Offering at $17/sh
-
Arcturus Therapeutics Announces Pricing of $70.0 Million Public Offering of Common Stock
-
Reed's (REED) Prices 13.3M Share Public Offering of Common Stock at $0.35/sh
-
Reed’s Inc. Prices Underwritten Public Offering of Common Stock
-
Reed's (REED) Plans Public Offering of Common Stock
-
Reed’s Inc. Announces Proposed Public Offering of Common Stock
-
Moderna (MRNA) PT Raised to $41 at Roth Capital
-
Roth Capital Resumes Lakeland Industries (LAKE) at Buy
-
Roth Capital Downgrades Yeti Holdings Inc. (YETi) to Neutral
-
Crinetics Pharmaceuticals (CRNX) Prices 7.15M Share Common Offering at $14/Sh
-
Roth Capital Starts Peloton Interactive (PTON) at Buy
-
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Roth Capital Starts Stealth BioTherapeutics (MITO) at Buy
-
Knowles Corp (KN) PT Lowered to $20 at Roth Capital, After Preliminary Earnings Reported
-
UPDATE: Roth Capital Starts Rapt Therapeutics (RAPT) at Buy
-
Netlist (NLST) PT Raised to $1 at Roth Capital
-
Companies with NDRs 4/08
-
Flower One Holdings Inc. (FONE:CN) (FLOOF) PT Lowered to Cdn$2 at Roth Capital, Following Earnings Preannouncement
-
MaxLinear (MXL) PT Lowered to $15 at Roth Capital, After Company Provides Earnings Guidance
-
Roth Capital Resumes Clarus Corp (CLAR) at Neutral
-
Roth Capital Starts Resideo Technologies (REZI) at Neutral
-
Roth Capital Starts Luxfer Holdings PLC (LXFR) at Buy
-
Roth Capital Assumes Parade Technologies Ltd. (PAR) at Neutral
-
BioNano Genomics, Inc. (BNGO) Prices 54.546M Share Common Offering at $0.18/Sh
-
BIONANO GENOMICS ANNOUNCES PRICING OF $18 MILLION UNDERWRITTEN PUBLIC OFFERING
-
Roth Capital Downgrades Jiayan Group (JFIN) to Neutral
-
Roth Capital Upgrades Earthstone Energy (ESTE) to Buy
-
Companies with NDRs 4/02
-
UPDATE: Roth Capital Downgrades Sunworks (SUNW) to Neutral
-
Therapix Biosciences (TRPX) Prices 4.167M ADS Share Offering
-
Therapix Biosciences Announces Pricing of $1.25 Million Public Offering
-
Roth Capital Upgrades Montage Resources Corp. (MR) to Buy
-
Companies with NDRs 4/01
-
Tengasco Announces Year-End 2019 Financials and Results of Operations

